Sectors:
Locations:
Min Investment:
Max Investment:
Target Investment:
Bachelor of Arts (B.A.)
Master of Science (MS)
2020
A pioneer in insurtech venture capital, American Family Ventures (AFV) is a multi-limited partner VC firm focused on the future of insurance. AFV invests in early-stage companies driving insurance innovation from inside the industry as well as from adjacent sectors. Limited partners span most major lines of insurance and represent over $100 billion in assets and over $35 billion in annual premiums.
2019 - 2020
2019 - 2020
Founder Equity is venture capital fund that invests in seed and early stage technology start-ups.
2019 - 2020
2019 - 2020
•Led development and cross-functional execution of go-to-market strategy for de novo Medicare Advantage health plans. •Oversaw management of plan performance and expansion through development of value-based provider partnerships.
2017 - 2019
•Business lead for designing risk-sharing arrangements for population health and specialty condition models including implementation of HCSC’s first Episode of Care program for hip/knee replacements, and leading design and funding efforts for an Oncology Medical Home, Dialysis Shared Savings program, and a Small Practice ACO. •Developed enterprise medical drug strategy across five states and accountable for implementation of contracting initiatives at the local plan level • Secured Innovation Funding from CMO and CTO to pilot a precision medicine decision support platform with community oncologists with the goal of improving progression free survival and reducing hospital utilization for members with metastatic cancers. •Led winning team in HCSC’s Future of Care Consumption competition for CEO and staff, which quantified the impact of emerging gene therapies on medical spend, identified avenues for developing outcomes-based agreements with drug manufacturers, and assessed new product line opportunities.
2016 - 2017
•Business owner for dynamic implementation of the Oncology Medical Home program, including oversight of cross-divisional work-streams from design to execution, communications to leadership on project status and risks, relationship management with CMS and vendors, contract review with legal teams, and management of day-to-day project escalations. •Led business case development of new value based care payment models, including financial model valuation, assessment of operational and IT impacts, and validation of market value proposition.
2015 - 2016
• Led strategy development for risk-based payment models, provider financial incentives, high - performing networks, and benefit design. • Targeted partnerships with hospital systems, group purchasing organizations, ancillary providers, and independent professionals to support diversification of long-term corporate strategy. • Supported scaling of HCSC’s payment transformation strategy through quantification of baseline medical spend in value based care programs and development of multi-year road map to scale new payment models
2014 - 2015
• Advanced multi-year network strategy for individual and small group Exchange-affected markets through evaluating service area expansion opportunities, assessing value-based contracting initiatives for risk-sharing arrangements. • Managed multi-divisional projects across network, product, medical management, and actuarial to meet unit cost targets in critical markets.
2013 - 2014
2013 - 2014
• Assessed business models of early-stage health IT companies for seed-stage investment and acceptance into Healthbox's accelerator programs • Managed company relationships with healthcare startups through targeted outreach initiatives in entrepreneur communities • Created an investor database, assessed health IT startup trends, and developed competitive analyses for portfolio companies
2010 - 2012
2010 - 2012
• Completed an Independent Honor’s Thesis on the seizure susceptibility of mice exhibiting a rare form of genetic epilepsy called Dravet's Syndrome, with the goal of informing future drug development to cure the disease in humans. • Research findings were published in the Journal of Neuroscience in 2015. • Awarded the Dalton/Zannoni Undergraduate Research Fellowship from the American Society for Pharmacology and Experimental Therapeutics (ASPET) in 2011.
2009 - 2010
•Conducted research on the the Mental Health Parity and Addiction Equity Act of 2008 and its limitations in alleviating inequities in insurance coverage faced by mental health patients.